Buchko GW, Hess NJ, Kennedy MA
3rd GLP-1 Based Therapeutics Summit 2026 14th April 2026 - April 16, 2026 The 3rd GLP-1 Based Therapeutics Summit is the essential industry forum dedicated to solving the critical challenges of GLP-1 combinations, mastering tolerability, drug delivery, and seizing the multi-billion dollar opportunity in non-obesity indications
Per publicly available announcements, the FDA issued more than 50 warning letters to GLP-1 compounders and manufacturers in September 2025, followed by an additional 30 warning letters to telehealth firms in early 2026, targeting false or misleading marketing claims about compounded semaglutide and tirzepatide products
Fibroids have both smooth muscle and fibroblast components, in addition to a substantial amount of fibrous extracellular matrix, which all contribute to the pathogenetic process
Interpersonal psychotherapy focuses on a persons relationship with others, including family, friends, and co-workers
doi: 10.1002/oby.22200 Sjstrm L, et al
